Golden-angle radial sparse parallel (GRASP) MRI in clinical routine detection of pituitary microadenomas: First experience and feasibility.
Adenoma
/ diagnostic imaging
Adult
Aged
Contrast Media
/ chemistry
Cysts
/ diagnostic imaging
Female
Human Growth Hormone
/ metabolism
Humans
Image Interpretation, Computer-Assisted
/ methods
Image Processing, Computer-Assisted
Magnetic Resonance Imaging
Male
Middle Aged
Observer Variation
Pituitary Gland
/ diagnostic imaging
Pituitary Neoplasms
/ diagnostic imaging
Prevalence
Prolactinoma
/ diagnostic imaging
Quality of Life
Reproducibility of Results
Retrospective Studies
Brain
Magnetic resonance imaging
Neoplasms
Pituitary MRI
Journal
Magnetic resonance imaging
ISSN: 1873-5894
Titre abrégé: Magn Reson Imaging
Pays: Netherlands
ID NLM: 8214883
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
23
01
2019
revised:
07
03
2019
accepted:
19
03
2019
pubmed:
1
4
2019
medline:
5
9
2019
entrez:
1
4
2019
Statut:
ppublish
Résumé
Background and purpose To demonstrate the clinical feasibility of a novel MRI pulse sequence, Golden-angle radial sparse parallel MRI (GRASP) through comparison to the current imaging technique, dynamic T1- weighted contrast enhanced (DCE) imaging in terms of image quality and lesion depiction in the detection of microlesions (microadenomas and cysts) of the pituitary gland. 16 patients (11 microadenomas, 5 cysts) underwent two MRI examinations (Siemens 1.5T and 3T) on separate dates, one using standard DCE (temporal resolution 30 s) and the other using GRASP (temporal resolution of 4.4 s). Two neuroradiologists separately recorded measures of image quality (Scale 1-5, 5 = best), lesion size and contrast arrival times in terms of first and best lesion conspicuity. In qualitiative analysis there were no significant differences in terms of average visual image sharpness (DCE 3.9 ± 0.9, GRASP 3.9 ± 0.9) or visual contrast scores (DCE 4.1 ± 1.2, GRASP 4.4 ± 0.8). Pearson's correlation coefficients for interreader lesion measurements (width and height, mm) ranged from substantial to almost perfect agreement (r = 0.73 to 0.88). Analysis of contrast arrival times revealed an average lesion first-conspicuity time of 60.7 ± 16.7 s for DCE compared to 50.2 ± 10.3 s for GRASP with a difference of 10.5 ± 16.2 s (p = 0.023). Depiction of pituitary microlesions is feasible with GRASP, which has the potential to increase sensitivity through higher temporal resolutions combined with isotropic acquisition allowing for multi-planar reconstructions; this remains to be proven in larger cohorts.
Identifiants
pubmed: 30928387
pii: S0730-725X(19)30060-8
doi: 10.1016/j.mri.2019.03.015
pii:
doi:
Substances chimiques
Contrast Media
0
Human Growth Hormone
12629-01-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
38-43Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.